<DOC>
	<DOCNO>NCT03015025</DOCNO>
	<brief_summary>The use coumarins challenge doctor narrow therapeutic range show great inter intra-individual variability dose necessary achieve international normalize ratio ( INR ) within therapeutic range . Among factor influence interindividual variability dose require include age , weight , Vitamin K diet , comorbidity well drug interaction recent year also see importance pharmacogenetic factor .</brief_summary>
	<brief_title>Pharmacogenetic Dosage Algorithm Acenocoumarol</brief_title>
	<detailed_description>Demographic clinical factor contribute approximately 20 % total variability dose requirement . In recent year highlight close relationship dose requirement coumarin drug certain polymorphisms gene involve pharmacokinetics pharmacodynamics drug . The use dose algorithm include pharmacogenetic information may help dose selection , improve efficacy reduce adverse event . Studies show relationship genotype variant CYP2C9 VKORC1 , CYP4F2 apolipoprotein E ( ApoE ) , together demographic clinical variant explain 50-60 % variability response drug .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Acenocoumarol</mesh_term>
	<criteria>Patients Auricular fibrillation , venous thromboembolic disease cardiac valve replacement receive acenocoumarol . Patients stable dose acenocoumarol ( weekly dose variation &lt; 20 % last 3 month ) . Patients international normalised ratio within range 2 3 ( Auricular Fibrillation venous thromboembolic disease ) 2.5 3.5 ( cardiac valve replacement ) least 3 previous consecutive month . Patients renal failure ( calculated creatinine clearance â‰¤30 ml/min ) , hepatic disease ( stage C Child Plough Stage ) , thyroid dysfunction and/or cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Acenocoumarol</keyword>
	<keyword>Cytochrome P450</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Algorithm</keyword>
	<keyword>CYP2C9</keyword>
	<keyword>VKORC1</keyword>
	<keyword>CYP4F2</keyword>
	<keyword>P450 oxidoreductase ( POR )</keyword>
</DOC>